News and Updates

World’s Largest Tire Manufacturers are Rolling Backwards on Sustainability

The tire industry accounts for 70% of rubber use around the world. Rubber harvesting practices in Southeast Asia and Africa are causing forests to rapidly disappear.

Former Congressman Henry Waxman Provides Guidance to Democrats Anticipating White House Investigations

In the final weeks preceding the 2018 midterm elections, Waxman Strategies’ Chairman and former Congressman Henry Waxman engaged in a series of interviews to elevate the benefits behind bipartisanship and the importance of effecting a credible and comprehensive investigation.

2018 Mid-Term Elections Insights from Waxman Strategies

Today, we are excited to launch the Waxman Strategies Elections Hub, where we are sharing insights into the potential policy scenarios that could play out in November and beyond.

Waxman and Mighty Earth Launch Stainless: The 100% Clean Energy Steel Campaign

Stainless: The 100% Clean Energy Steel campaign aims to transition the steel industry to 100 percent clean energy for its electricity supply, starting with Nucor Corporation, the largest steel producer in the United States.

Congress is Making Quiet Progress on Drug Costs

The Commonwealth Fund published a To the Point blog post detailing the incremental steps that Congress has taken on policies that would lower drug costs for patients.

Hatch Amendment Could Delay Generic Drug Competition and Increase Drug Prices

If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.

California Health Care Foundation Interviews Waxman Strategies Chairman Henry Waxman on the Future of Health Policy

California Health Care Foundation (CHCF) interviews  Waxman Strategies Chairman Henry Waxman on the changing political landscape of health care reform.

Former Congress Henry Waxman Speaks About Drug Prices and the Affordable Care Act at Spotlight Health in Aspen, CO

Former Congressman Henry Waxman (D-Calif.) and chairman of Waxman Strategies participated last weekend in the Aspen Institute’s annual Spotlight Health event to talk about rising prescription drug prices, as well as, reminisce on the Affordable Care Act (ACA).

Analyzing the US Food and Drug Administration’s Plans to Increase Competition in Response to High Drug Prices

Prescription drug prices have reached an all-time high. FDA Commissioner Gottlieb has taken on the issue indirectly, and announced several actions by the FDA intended to increase generic drug competition and transparency.

Fishy Culprits Threaten Our Oceans

For the past 42 years, the United States has enjoyed the advantages of robust, efficient federal fisheries management systems that the recreational fishing lobby is now threatening with funding from special interest groups.